Department of Pharmacology, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, P.O. Box 1057 Blindern, 0316 Oslo, Norway.
Int J Mol Sci. 2022 Feb 15;23(4):2145. doi: 10.3390/ijms23042145.
Cardiac contractility is regulated by several neural, hormonal, paracrine, and autocrine factors. Amongst these, signaling through β-adrenergic and serotonin receptors generates the second messenger cyclic AMP (cAMP), whereas activation of natriuretic peptide receptors and soluble guanylyl cyclases generates cyclic GMP (cGMP). Both cyclic nucleotides regulate cardiac contractility through several mechanisms. Phosphodiesterases (PDEs) are enzymes that degrade cAMP and cGMP and therefore determine the dynamics of their downstream effects. In addition, the intracellular localization of the different PDEs may contribute to regulation of compartmented signaling of cAMP and cGMP. In this review, we will focus on the role of PDEs in regulating contractility and evaluate changes in heart failure.
心肌收缩力受多种神经、激素、旁分泌和自分泌因素的调节。在这些因素中,β肾上腺素能和 5-羟色胺受体的信号转导产生第二信使环磷酸腺苷(cAMP),而利钠肽受体和可溶性鸟苷酸环化酶的激活则产生环磷酸鸟苷(cGMP)。这两种环核苷酸通过多种机制调节心肌收缩力。磷酸二酯酶(PDEs)是降解 cAMP 和 cGMP 的酶,因此决定了它们下游效应的动力学。此外,不同 PDE 的细胞内定位可能有助于调节 cAMP 和 cGMP 的分隔信号转导。在这篇综述中,我们将重点介绍 PDE 在调节收缩力中的作用,并评估心力衰竭时的变化。